SlideShare a Scribd company logo
In Process Quality Control Tests
(IPQC) for solid dosage from
IPQC Sagar Kishor Savale
In Process Quality Control Tests (IPQC) for solid dosage from
Mr. Sagar Kishor Savale
M. Pharm (Pharmaceutics)
IPQC Sagar Kishor Savale
In Process Quality Control Tests (IPQC)
IPQC is concerned with providing accurate, specific, & definite descriptions of the
procedures to be employed, from, the receipt of raw materials to the release of the finished
dosage forms.
 In process Quality Control, IPQC tests are mostly performed within the production
area.
 They should not carry any risk for the quality of product.
 In process testing enables easier identification of problems. It sometime identifies
a defective product batch that can be corrected by rework, whereas once that batch
has been completed, this may not be possible.
 Failure to meet in process control specification indicates either that procedure were
not followed or some factor (S) out of control.
IPQC Sagar Kishor Savale
Instrument used in IPQC department
 Disintegration apparatus
 Dissolution apparatus
 Analytical balance Muffle furnace
 Friability testing apparatus
 Bulk density apparatus
 Tablet hardness tester
 Infra-red moisture content measuring apparatus
 U.V Spectroscopy
 Abbe Refractometer
 T.L.C. kit
 Karl fisher Titrimeter
IPQC Sagar Kishor Savale
Official and Unofficial Tests for Evaluation of Tablets
Official Tests
[1] Weight variation
[2] Disintegration
[3] Dissolution
[4] Drug content
Non-Official Tests
[1] Hardness
[2] Friability
IPQC Sagar Kishor Savale
1. Weight variation test (uniformity of weight)
Weigh 20 tablet selected at random, each one individually. X1, X2, X3… Xz
Determine the average weight. X= (X1+X2 +X3+…+ Xz)/20
Limit:
 Upper limit = average weight + (average weight * % error)
 Lower limit = average weight - (average weight * % error)
 The individual weights are compared with the upper and lower limits.
 Not more than two of the tablets differ from the average weight by more than the
% error listed, and no tablet differs by more than double that percentage.
Weight Variation Tolerances for Uncoated Tablets
USP XX-NF STANDARDS
IP STANDARDS
Sr. No Average wt. of tablet(mg) Max. % difference allowed
1 84 or Less 10%
2 84-250 7.5%
3 More than 250 5%
Sr. No Average wt. of tablet(mg) Max. % difference allowed
1 130 or Less 10%
2 130-324 7.5%
3 More than 324 5%
IPQC Sagar Kishor Savale
2. Content Uniformity Test
Randomly select 30 tablets. 10 of these assayed individually. The Tablet pass the test if 9
of the 10 tablets must contain not less than 85 % and not more than 115 % of the labeled
drug content and the 10th
tablet may not contain less than 75 % and more than125 % of the
labeled content. If these conditions are not met, remaining 20 tablet assayed individually
and none may fall outside of the 85 to 115 % range.
3. Disintegration test (U.S.P.)
 It is the time required for the tablet to break into particles, the disintegration test is
a measure only of the time required under a given set of conditions for a group of
tablets to disintegrate into particles.
 It is performed to identify the disintegration of tablet in particular time period.
 Disintegration test is not performed for controlled & sustained release tablets.
 According to the test the tablet must disintegrate and all particles must pass through
the 10 mesh screen in the time specified. If any residue remains, it must have a soft
mass.
Disintegration test apparatus
IPQC Sagar Kishor Savale
Disintegration Media
 Water,
 Simulated gastric fluid (pH = 1.2 HCl), or Simulated intestinal fluid (pH = 7.5,
KH2PO4 (phosphate buffer) + pancreatic enzyme + NaOH)
Disintegration Testing Conditions and Interpretation
Sr. no. Type of tablets Medium Temperature limit
1 Compressed
uncoated
37 ± 2 0
C 15 minutes or as per
individual monograph
2 Sugar coated
If 1 or 2 tablets fail
Water
0.1 N HCL
37 ± 2 0
C 60 minutes or as per
individual monograph
3 Film coated water 37 ± 2 0
C 30 minutes or as per
individual monograph
4 Enteric coated 0.1 N HCL &
Phosphate
buffer pH 6.8
37 ± 2 0
C 1 hr or as per individual
monograph
5 Dispersible/
Effervescent
water 37 ± 2 0
C LST < 3 minutes or as
per individual
monograph
6 Buccal 37 ± 2 0
C 4 hr or as per individual
monograph
IPQC Sagar Kishor Savale
U.S.P. method for uncoated tablets
 Start the disintegration test on 6 tablets.
 If one or two tablets from the 6 tablets fail disintegrate completely within 30 min
repeat the same test on another 12 tablet. (i.e. the whole test will consume 18
tablets).
 Not less then 16 tablets disintegrate completely within the time
 If more than two tablets (from the 18) fail to disintegrate, the batch must be rejected.
For Coated tablets
 To remove or dissolve the coat, immerse the tablet in distilled water for 5min.
 Put the tablet in the apparatus in water or HCL for 30 min at 37o
C (according to the
U.S.P). If not disintegrated, put in intestinal fluid.
 If one or two tablets fail to disintegrate, repeat on 12 tablets. So 16 tablets from the
18 must completely disintegrate within the time, if two or more not disintegrated
the batch is rejected.
U.S.P. and B.P Method for Enteric coated tablets
 Put in distilled water for five minutes to dissolve the coat.
 Then put in simulated gastric fluid (0.1M HCL) for one hour.
 Then put in simulated intestinal fluid for two hours.
 If one or two tablets fail to disintegrate, repeat this test on another 12 tablets. So 16
tablets from 18 should completely disintegrate. If more than two fail to disintegrate
the Batch must be rejected.
IPQC Sagar Kishor Savale
4. Dissolution Test
 Dissolution is performed to check the percentage release from the dosage forms.
i.e. Tablet.
 Tablet breaks down into small particles which offers a greater surface area to the
dissolving media.
 Disintegration test does not give assurance that particles will release drug in
solution at an appropriate rate, that’s why dissolution tests & its specifications
developed for all tablet products.
 Dissolution is mass transfer process.
 Dissolution is mainly depend on aqueous solubility of drug.
 It is process in which solid mass transfer in liquid medium.
 Dissolution based on four process – 1. wetting 2. Solubility 3. Swelling 4.
Diffusion.
 Particle size, shape, surface area is important factor can affect the rate of
dissolution of drug.
 The aqueous solubility is increases, increases rate of dissolution drug.
IPQC Sagar Kishor Savale
 Dissolution- solid mass transfer process in to liquid medium.
 Diffusion- diffusion is mass transfer process of individual molecules of atoms
having continuous random molecular motion contain in concentration gradient is
known has Diffusion.
 Dialysis- separation of easily diffusible particle from poorly diffusible particle
through semipermeable Membrane.
 Ultrafiltration- separation of colloidal particle from sub colloidal particle through
semipermeable membrane.
 Osmosis- The passage of solvent molecule into solution through semipermeable
membrane.
 Semipermeable membrane – Thin layer that can separate two phases.
 Steady sate- Mass transfer process is remains constant per unit time.
 Non steady state- Mass transfer process is not remains constant per unit time.
 Osmotic pressure- The pressure is exerted in walls of semipermeable membrane
through concentration gradient.
 Diffusant (penetrant) - the amount of material transport in semipermeable
membrane.
 Con. Gradient- concentration of material transport in region of high con. To region
of low con.
Mechanism of Dissolution
 Dissolution is a mass transfer process.
 Sink condition – The concentration of receptor compartment is maintain lower
level as compared to Donor compartment is known as sink condition.
 Non sink condition – The concentration of receptor compartment is not
maintain at lower level as compared to donor compartment.
IPQC Sagar Kishor Savale
Theories of Drug Dissolution
 Diffusion layer model/Film Theory
 Danckwert’s model/Penetration or surface renewal Theory
 Interfacial barrier model/Double barrier or Limited solvation theory
IPQC Sagar Kishor Savale
Factor affecting dissolution rate
 Physicochemical Properties of Drug
 Drug Product Formulation Factors
 Processing Factors
 Factors Relating Dissolution Apparatus
 Factors Relating Dissolution Test Parameters
Dissolution test apparatus
IP apparatus
[1] First is Paddle apparatus (IP)
[2] Second is Basket apparatus (IP)
USP apparatus
1. Apparatus 1 (rotating basket)
2. Apparatus 2 (paddle assembly)
3. Apparatus 3 (reciprocating cylinder)
4. Apparatus 4 (flow-through cell)
5. Apparatus 5 (paddle over disk)
6. Apparatus 6 (cylinder)
7. Apparatus 7 (reciprocating holder)
IPQC Sagar Kishor Savale
USP Dissolution apparatus I (Basket method)
A single tablet is placed in a small wire mesh basket attached to the bottom of the shaft
connected to a variable speed motor. The basket is immersed in a dissolution medium (as
specified in monograph) contained in a 1000 ml flask. The flask is cylindrical with a
hemispherical bottom. The flask is maintained at 37 ± 0.50
C by a constant temperature
bath. The motor is adjusted to turn at the specified speed and sample of the fluid are
withdrawn at intervals to determine the amount of drug in solutions.
IPQC Sagar Kishor Savale
USP Dissolution apparatus II (Paddle method)
It is same as apparatus-1, except the basket is replaced by a paddle. The dosage form is
allowed to sink to the bottom of the flask before stirring. For dissolution test U.S.P.
specifies the dissolution test medium and volume, type of apparatus to be used, rpm of the
shaft, time limit of the test and assay procedure for. The test tolerance is expressed as a %
of the labeled amount of drug dissolved in the time limit.
IPQC Sagar Kishor Savale
Dissolution Testing and Interpretation IP Standards
Sr.no. Quantity
Stage/level
Number of
tablets tested
Acceptance criteria
1 S1 6 Each unit is < D* + 5 percent**
2 S2 6 Average of 12 units (S1 +S2) is equal to or greater
than (> )D, and no unit is less than D - 15 percent**
3 S3 12 Average of 24 units (S1+S2+S3) is equal to or
greater than (> )D, not more than 2 units are less
than d-15 percent** and no unit is less than d-25
percent**
*D is the amount of dissolved active ingredient specified in the individual monograph, expressed
as a percentage of the labelled content.
** Percentages of the labelled content.
Dosage from conducted dissolution study
Immediate release tablet (conventional tablet)
1. Dissolution apparatus – Type 1 and Type 2 (USP)
2. Temperature - 37±0.5˚C
3. Time – 30 min
4. Time of interval – 5, 10, 15, 20, 25, 30.
5. Media – PH 1.2 Acidic Buffer, PH 4.5 Acetate buffer, PH 5.8 Phosphate buffer.
(depending upon tablet)
6. Rpm – 75 -100 rpm
7. Volume – 900 ml
Procedure: The tablet was added into cylindrical vessel containing 1000 ml dissolution
media having rpm 75 and tem.37±0.5˚C. Dissolution of tablet was conducted 30 min,
in 5 min. of interval, after 5 min 5 mL sample was removed and appropriate quantity
of sample take absorbance by using U.V. spectroscopy technique and determine rate of
dissolution of tablet.
IPQC Sagar Kishor Savale
Sustained release tablet
1. Dissolution apparatus – Type 2 (USP)
2. Temperature - 37±0.5˚C
3. Time – 7 hrs
4. Media – PH 1.2 Acidic Buffer, PH 6.8 Phosphate buffer.
5. Rpm – 75 – 100.
6. Volume – 900 ml.
Procedure - The tablet was added into cylindrical vessel containing 1000 ml PH 1.2 Acidic
media having rpm 75 for next two hours and tem. 37±0.5˚C. Dissolution media was
changes tablet was added in to PH 6.8 Phosphate buffer for next five hour for 1 hr. of
interval. After 1 hr. 5 mL sample was removed and appropriate quantity of sample take
absorbance by using U.V. spectroscopy technique and determine rate of dissolution of
tablet.
Capsule
1. Dissolution apparatus – Type 2 (USP)
2. Temperature - 37±0.5˚C
3. Time – 5 hrs.
4. Media – PH 1.2 Acidic Buffer, PH 6.8 Phosphate buffer.
5. Rpm – 75 – 100.
6. Volume – 900 ml.
Procedure - The Capsule was added into cylindrical vessel containing 1000 ml PH 1.2
Acidic media having rpm 75 for next two hours and tem. 37±0.5˚C. Dissolution media was
changes Capsule was added in to PH 6.8 Phosphate buffer for next three hour for 1 hr. of
interval. After 1 hr. 5 mL sample was removed and appropriate quantity of sample take
absorbance by using U.V. spectroscopy technique and determine rate of dissolution of
Capsule.
IPQC Sagar Kishor Savale
Suppositories
1. Dissolution apparatus – Type 1 (USP)
2. Temperature - 37±0.5˚C
3. Time – 60 min
4. Time of interval – 10, 20, 30, 40, 50, 60.
5. Media – PH 7.4 Phosphate buffer.
6. Rpm – 50 – 75 rpm
7. Volume – 900 ml.
Procedure – The Suppository was added into cylindrical vessel containing 1000 ml
dissolution media (PH 7.4 Phosphate buffer) having rpm 75 and tem.37±0.5˚C. Dissolution
of Suppository was conducted 60 min, in 10 min. of interval, after 10 min 5 ml sample was
removed and appropriate quantity of sample take absorbance by using U.V. spectroscopy
technique and determine rate of dissolution of Suppositories.
5. Hardness
Tablet requires a certain amount of strength or hardness and resistance to friability to
withstand mechanical shocks of handling in manufacture, packaging and shipping.
Hardness generally measures the tablet crushing strength.
Importance
 To determine the need for pressure adjustments on the tableting machine.
 Hardness can affect the disintegration.
 So if the tablet is too hard, it may not disintegrate in the required period of time.
And if the tablet is too soft, it will not withstand the handling during subsequent
processing such as coating or packaging.
 In general, if the tablet hardness is too high, we first check its disintegration before
rejecting the batch.
 If the disintegration is within limit, we accept the batch.
IPQC Sagar Kishor Savale
 If Hardness is high + disintegration is within a time accept the batch.
Factors Affecting the Hardness
[1] Compression of the tablet and compressive force.
[2] Amount of binder. (More binder à more hardness)
[3] Method of granulation in preparing the tablet (wet method gives more hardness
than direct method, Slugging method gives the best hardness).
Limits
5 kilograms minimum and 8 kilograms maximum.
Make hardness test on 5 tablets and then take the average hardness.
IPQC Sagar Kishor Savale
6. Friability
Friability of a tablet can determine in laboratory by Roche friabilator. This consist of a
plastic chamber that revolves at 25 rpm, dropping the tablets through a Distance of six
inches in the friabilator, which is then operate for 100 revolutions. The tablets are
reweighed. Compress tablet that lose less than 0.5 to 1.0 % of the Tablet weigh are consider
acceptable.
Friability apparatus
Evaluation of Precompressional Characteristics of tablets or
Rheological Characteristics of granules
Particle Size & Shape Determination
 Size affects the average weight of tablet, Disintegration Time, weight variation,
friability, flow ability & drying rate.
 The size & shape depends upon processing requirements & during granulation.
 The methods for determining size & shape are
1. Sieving
2. Sedimentation rate.
3. Microscopy (SEM)
4. Light Scattering
IPQC Sagar Kishor Savale
Surface area
 It is not commonly used for granules but generally used for drug substances.
 If required particle size is measured & from this surface area is measured.
 Most method used is gas absorption & air permeability.
 In gas absorption, gas is absorbed as monolayer on particles this is in term of
calculated & converted to surface area.
 In air permeability method the rate of air permeates a bed of powder, is used to
calculate surface area of powder sample.
Density
 Density may influence compressibility, tablet porosity & dissolution.
 Dense hard granules may require higher load to produce cohesive compact to
reduce free granules seen on the surface of tablets.
 ↑ Compressibility ↑ DT, Dissolution, if DT is slower dissolution is indirectly
hampered.
 Dense granules have less friability but cause a problem in releasing the drug.
 Three Methods to determine density
Bulk Density
Bulk density is given by equation,
ρb = M / Vb
Where,
ρb- bulk density of granules,
M is mass of granules in gm,
Vb – volume of granules in measuring cylinder in ml.
More compressible bed of particulate - less flowable powder or granules.
If less dense/compressible - more flowable powder or granules.
True/tapped density
Tapped/true density is given by equation,
ρt = M / Vb
Where,
IPQC Sagar Kishor Savale
ρt- bulk density of granules,
M is mass of granules in gm,
Vt – volume of granules in measuring cylinder after tapping in ml.
Granular density
It is determined by Pycnometer method.
 Two methods are used to determined granular density.
 In one intrusion fluid used-Mercury, and other
Any solvent of low surface tension e.g. Benzene
 The accuracy of these method depends upon ability of intrusion fluid to penetrate
the pores of granules.
 Liquids should not masks granules solubilies in it, & having property to penetrate
the pores.
 Density is then determine from volume of intrusion fluid displaced in pycnometer
by giving mass of granulation.
It is calculated by using equation,
Granular Density (D) = M / Vp -Vi
Where, Vp-Total volume of Pycnometer, Vi- Volume of intrusion fluid (ml) containing
Mass (gm) (M) of granules required to fill pycnometer.
Angle of repose – It is measured by two methods
 Static angle of repose
 Dynamic angle of repose
Equation is, tan θ = h/r.
Where, θ - angle of repose, h – height of pile, r – radius of pile.
IPQC Sagar Kishor Savale
Acceptance limits of angle of repose
Sr. no. Angle of repose (o) Type of flow
1 < 25 Excellent
2 25-30 Good
3 30-40 passable
4 > 40 Poor
Hausner's Ratio
 Hausner’s ratio was related to interparticulate friction and as such could be
used to predict powder flow characteristics.
 It showed that powder with low particular friction such as coarse sphere had ratio
of approximately 1.2, whereas more as cohesiveness- less free flowing powders
such as flaks have Hausner’s ratio greater than 1.6.
Formula
Hausner’s ratio = Tapped density / Bulk density
IPQC Sagar Kishor Savale
Moisture content
 The amount of moisture present in the granule is called moisture content.
 Generally the granules contain 2 % moisture. It is required for the binding of the
powder or granules during compression in die cavity.
 Percentage of moisture is calculated by using “moisture Balance” or “IR Balance”.
 IR Balance consist of simple balance which is placed I to the casing in which the
IR bulb is attached which produce heat inside the chamber.
 The small amount of sample taken from oven to measure moisture content & place
in the moisture balance.
 Initial reading should be note down after that we are initiated the IR Bulb as IR
bulb is initiated the moisture is removed from the granules via heating after that
note down the reading.
% of moisture is calculated by,
% moisture content = Initial wt. - Final wt./ initial weight X 100
Compressibility Index
 It is directly related to the relative flow rate cohesiveness & particle size.
 It is simple fast & popular method of presiding powder flow characters.
It can be obtained from bulk density measurements is the % Compressibility index (C).
% Compressibility index = Tapped density - Bulk density / Tapped density X 100.
OR
I = (1 – V/ Vo) x 100
Where,
I – % Compressibility index,
V – Volume occupied by powder/ granules after tapping, Vo - volume of powder/granules
before tapping
IPQC Sagar Kishor Savale
Acceptance limit Compressibility index
Sr. no. % Compressibility index Type of flow
1 5-15 Excellent
2 12-16 Very good
3 18-21 Good
4 23-25 Passable
5 33-38 Poor
6 > 40 Very poor
IPQC Sagar Kishor Savale
Process control by means of in-process controls
IPQC Sagar Kishor Savale
Example of an IPQC structure
IPQC Sagar Kishor Savale
Example of Approval for Tablet Production
Contact
Savalesagar484@gmail.com
+91 9960885333

More Related Content

PPTX
IPQC and FPQC tests for Tablets
PPTX
Ipqc tests for tablet
PPTX
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
PPTX
Ipqc test of tablet
PPTX
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...
PPTX
IPQC and FPQC for tablets
PPTX
IPQC of dosage form in pharmaceutical industry
PPTX
IPQC Test for Liquid Dosage Forms
IPQC and FPQC tests for Tablets
Ipqc tests for tablet
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
Ipqc test of tablet
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...
IPQC and FPQC for tablets
IPQC of dosage form in pharmaceutical industry
IPQC Test for Liquid Dosage Forms

What's hot (20)

PPTX
ICH Guidelines
PPTX
Pharmaceutical Qualification & Validation
PPTX
Ich guidelines Q1A(R2)
PPTX
Quality control test of tablets
PPTX
Validation master plan
PPT
Preformulation testing of solid dosage forms
PPTX
Selection and evaluation of pharmaceutical packaging materials, containers an...
PPTX
ICH guidelines (Q,S,E,M)
PPTX
Quality Control Test For Suspensions
PPTX
Pharmaceutical Containers and Closures: An Overview
PPTX
Pre formulation protocol
PPTX
Ipqc tests for suspension &amp; emulsion ppt
PPTX
IPQC for capsule.
PPTX
Ipqc for parenterals
PPTX
IPQC and FPQC test for semi solids dosage form....pptx
PPTX
Analytical method transfer
PPTX
PPTX
Technology transfer from R&D to production
PPT
Dissolution Testing Apparatus
PPT
Dissolution testing
ICH Guidelines
Pharmaceutical Qualification & Validation
Ich guidelines Q1A(R2)
Quality control test of tablets
Validation master plan
Preformulation testing of solid dosage forms
Selection and evaluation of pharmaceutical packaging materials, containers an...
ICH guidelines (Q,S,E,M)
Quality Control Test For Suspensions
Pharmaceutical Containers and Closures: An Overview
Pre formulation protocol
Ipqc tests for suspension &amp; emulsion ppt
IPQC for capsule.
Ipqc for parenterals
IPQC and FPQC test for semi solids dosage form....pptx
Analytical method transfer
Technology transfer from R&D to production
Dissolution Testing Apparatus
Dissolution testing
Ad

Similar to In Process Quality Control Tests (IPQC) for Solid Dosage From (20)

PPTX
Ipqc tests for tablets
PPTX
IPQC for tablets, capsules and ointments.pptx
PDF
In-Process & Finished Product Quality Control_Tablet.pdf
PPTX
Non sterile manufacturing process technology
PPTX
Non sterile manufacturing process technology
PPTX
PPT-MQA103T-3- quality control and quality assurance
PPTX
MQA103T-3-Quality Control and Quality Assurance
PPTX
IN PROCESS QUALITY CONTROL TEST FOR TABLETS
PPTX
INPROCESS QUALITY CONTROL.pptx
PPTX
Ipqc for tablets correctd
PPTX
IPQC Seminar.pptx
PPTX
IN-PROCESS QUALITY CONTROL TESTS - IPQC OF TABLETS ppt
PPTX
IPQC AND FPQC test of tablet.pptx
PPTX
An orientation lecture For M.Pharm
PPTX
Disintegration and dissolution tests
PPTX
IPQC TESTS
PPTX
Ipqc tests of various dosage form
PPT
Quality control tests for tablets
PPTX
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry
PPTX
Inprocess as per usp ip bp tablets
Ipqc tests for tablets
IPQC for tablets, capsules and ointments.pptx
In-Process & Finished Product Quality Control_Tablet.pdf
Non sterile manufacturing process technology
Non sterile manufacturing process technology
PPT-MQA103T-3- quality control and quality assurance
MQA103T-3-Quality Control and Quality Assurance
IN PROCESS QUALITY CONTROL TEST FOR TABLETS
INPROCESS QUALITY CONTROL.pptx
Ipqc for tablets correctd
IPQC Seminar.pptx
IN-PROCESS QUALITY CONTROL TESTS - IPQC OF TABLETS ppt
IPQC AND FPQC test of tablet.pptx
An orientation lecture For M.Pharm
Disintegration and dissolution tests
IPQC TESTS
Ipqc tests of various dosage form
Quality control tests for tablets
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry
Inprocess as per usp ip bp tablets
Ad

More from Sagar K Savale (20)

PDF
Scale up and Post Approval Chenges (SUPAC).pdf
PDF
Sagar K Savale _ Publons.pdf
PDF
Sagar Savale (0000-0001-5467-2038) - ORCID _ Connecting Research and Research...
PDF
Omicron covid variant: a short overview
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
LinkedIn Certificate
PDF
E - certificate ijsrem.com sagar kishor savale
PDF
Certificate of completion time management fundamentals with microsoft office
PDF
Certificate of completion the data science of healthcare, medicine, and publi...
PDF
Certificate of completion microsoft project quick tips
PDF
Certificate of completion improving your judgment for better decision-making
PDF
Certificate of completion data visualization_ best practices
Scale up and Post Approval Chenges (SUPAC).pdf
Sagar K Savale _ Publons.pdf
Sagar Savale (0000-0001-5467-2038) - ORCID _ Connecting Research and Research...
Omicron covid variant: a short overview
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
LinkedIn Certificate
E - certificate ijsrem.com sagar kishor savale
Certificate of completion time management fundamentals with microsoft office
Certificate of completion the data science of healthcare, medicine, and publi...
Certificate of completion microsoft project quick tips
Certificate of completion improving your judgment for better decision-making
Certificate of completion data visualization_ best practices

Recently uploaded (20)

PPT
Breast Cancer management for medicsl student.ppt
PPTX
Uterus anatomy embryology, and clinical aspects
PPTX
Slider: TOC sampling methods for cleaning validation
PPT
Obstructive sleep apnea in orthodontics treatment
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
Neuropathic pain.ppt treatment managment
PPTX
Acid Base Disorders educational power point.pptx
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
1 General Principles of Radiotherapy.pptx
PPTX
Gastroschisis- Clinical Overview 18112311
DOCX
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPTX
Note on Abortion.pptx for the student note
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
Breast Cancer management for medicsl student.ppt
Uterus anatomy embryology, and clinical aspects
Slider: TOC sampling methods for cleaning validation
Obstructive sleep apnea in orthodontics treatment
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
CT Anatomy for Radiotherapy.pdf eryuioooop
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Neuropathic pain.ppt treatment managment
Acid Base Disorders educational power point.pptx
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
Respiratory drugs, drugs acting on the respi system
1 General Principles of Radiotherapy.pptx
Gastroschisis- Clinical Overview 18112311
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
Note on Abortion.pptx for the student note
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx

In Process Quality Control Tests (IPQC) for Solid Dosage From

  • 1. In Process Quality Control Tests (IPQC) for solid dosage from
  • 2. IPQC Sagar Kishor Savale In Process Quality Control Tests (IPQC) for solid dosage from Mr. Sagar Kishor Savale M. Pharm (Pharmaceutics)
  • 3. IPQC Sagar Kishor Savale In Process Quality Control Tests (IPQC) IPQC is concerned with providing accurate, specific, & definite descriptions of the procedures to be employed, from, the receipt of raw materials to the release of the finished dosage forms.  In process Quality Control, IPQC tests are mostly performed within the production area.  They should not carry any risk for the quality of product.  In process testing enables easier identification of problems. It sometime identifies a defective product batch that can be corrected by rework, whereas once that batch has been completed, this may not be possible.  Failure to meet in process control specification indicates either that procedure were not followed or some factor (S) out of control.
  • 4. IPQC Sagar Kishor Savale Instrument used in IPQC department  Disintegration apparatus  Dissolution apparatus  Analytical balance Muffle furnace  Friability testing apparatus  Bulk density apparatus  Tablet hardness tester  Infra-red moisture content measuring apparatus  U.V Spectroscopy  Abbe Refractometer  T.L.C. kit  Karl fisher Titrimeter
  • 5. IPQC Sagar Kishor Savale Official and Unofficial Tests for Evaluation of Tablets Official Tests [1] Weight variation [2] Disintegration [3] Dissolution [4] Drug content Non-Official Tests [1] Hardness [2] Friability
  • 6. IPQC Sagar Kishor Savale 1. Weight variation test (uniformity of weight) Weigh 20 tablet selected at random, each one individually. X1, X2, X3… Xz Determine the average weight. X= (X1+X2 +X3+…+ Xz)/20 Limit:  Upper limit = average weight + (average weight * % error)  Lower limit = average weight - (average weight * % error)  The individual weights are compared with the upper and lower limits.  Not more than two of the tablets differ from the average weight by more than the % error listed, and no tablet differs by more than double that percentage. Weight Variation Tolerances for Uncoated Tablets USP XX-NF STANDARDS IP STANDARDS Sr. No Average wt. of tablet(mg) Max. % difference allowed 1 84 or Less 10% 2 84-250 7.5% 3 More than 250 5% Sr. No Average wt. of tablet(mg) Max. % difference allowed 1 130 or Less 10% 2 130-324 7.5% 3 More than 324 5%
  • 7. IPQC Sagar Kishor Savale 2. Content Uniformity Test Randomly select 30 tablets. 10 of these assayed individually. The Tablet pass the test if 9 of the 10 tablets must contain not less than 85 % and not more than 115 % of the labeled drug content and the 10th tablet may not contain less than 75 % and more than125 % of the labeled content. If these conditions are not met, remaining 20 tablet assayed individually and none may fall outside of the 85 to 115 % range. 3. Disintegration test (U.S.P.)  It is the time required for the tablet to break into particles, the disintegration test is a measure only of the time required under a given set of conditions for a group of tablets to disintegrate into particles.  It is performed to identify the disintegration of tablet in particular time period.  Disintegration test is not performed for controlled & sustained release tablets.  According to the test the tablet must disintegrate and all particles must pass through the 10 mesh screen in the time specified. If any residue remains, it must have a soft mass. Disintegration test apparatus
  • 8. IPQC Sagar Kishor Savale Disintegration Media  Water,  Simulated gastric fluid (pH = 1.2 HCl), or Simulated intestinal fluid (pH = 7.5, KH2PO4 (phosphate buffer) + pancreatic enzyme + NaOH) Disintegration Testing Conditions and Interpretation Sr. no. Type of tablets Medium Temperature limit 1 Compressed uncoated 37 ± 2 0 C 15 minutes or as per individual monograph 2 Sugar coated If 1 or 2 tablets fail Water 0.1 N HCL 37 ± 2 0 C 60 minutes or as per individual monograph 3 Film coated water 37 ± 2 0 C 30 minutes or as per individual monograph 4 Enteric coated 0.1 N HCL & Phosphate buffer pH 6.8 37 ± 2 0 C 1 hr or as per individual monograph 5 Dispersible/ Effervescent water 37 ± 2 0 C LST < 3 minutes or as per individual monograph 6 Buccal 37 ± 2 0 C 4 hr or as per individual monograph
  • 9. IPQC Sagar Kishor Savale U.S.P. method for uncoated tablets  Start the disintegration test on 6 tablets.  If one or two tablets from the 6 tablets fail disintegrate completely within 30 min repeat the same test on another 12 tablet. (i.e. the whole test will consume 18 tablets).  Not less then 16 tablets disintegrate completely within the time  If more than two tablets (from the 18) fail to disintegrate, the batch must be rejected. For Coated tablets  To remove or dissolve the coat, immerse the tablet in distilled water for 5min.  Put the tablet in the apparatus in water or HCL for 30 min at 37o C (according to the U.S.P). If not disintegrated, put in intestinal fluid.  If one or two tablets fail to disintegrate, repeat on 12 tablets. So 16 tablets from the 18 must completely disintegrate within the time, if two or more not disintegrated the batch is rejected. U.S.P. and B.P Method for Enteric coated tablets  Put in distilled water for five minutes to dissolve the coat.  Then put in simulated gastric fluid (0.1M HCL) for one hour.  Then put in simulated intestinal fluid for two hours.  If one or two tablets fail to disintegrate, repeat this test on another 12 tablets. So 16 tablets from 18 should completely disintegrate. If more than two fail to disintegrate the Batch must be rejected.
  • 10. IPQC Sagar Kishor Savale 4. Dissolution Test  Dissolution is performed to check the percentage release from the dosage forms. i.e. Tablet.  Tablet breaks down into small particles which offers a greater surface area to the dissolving media.  Disintegration test does not give assurance that particles will release drug in solution at an appropriate rate, that’s why dissolution tests & its specifications developed for all tablet products.  Dissolution is mass transfer process.  Dissolution is mainly depend on aqueous solubility of drug.  It is process in which solid mass transfer in liquid medium.  Dissolution based on four process – 1. wetting 2. Solubility 3. Swelling 4. Diffusion.  Particle size, shape, surface area is important factor can affect the rate of dissolution of drug.  The aqueous solubility is increases, increases rate of dissolution drug.
  • 11. IPQC Sagar Kishor Savale  Dissolution- solid mass transfer process in to liquid medium.  Diffusion- diffusion is mass transfer process of individual molecules of atoms having continuous random molecular motion contain in concentration gradient is known has Diffusion.  Dialysis- separation of easily diffusible particle from poorly diffusible particle through semipermeable Membrane.  Ultrafiltration- separation of colloidal particle from sub colloidal particle through semipermeable membrane.  Osmosis- The passage of solvent molecule into solution through semipermeable membrane.  Semipermeable membrane – Thin layer that can separate two phases.  Steady sate- Mass transfer process is remains constant per unit time.  Non steady state- Mass transfer process is not remains constant per unit time.  Osmotic pressure- The pressure is exerted in walls of semipermeable membrane through concentration gradient.  Diffusant (penetrant) - the amount of material transport in semipermeable membrane.  Con. Gradient- concentration of material transport in region of high con. To region of low con. Mechanism of Dissolution  Dissolution is a mass transfer process.  Sink condition – The concentration of receptor compartment is maintain lower level as compared to Donor compartment is known as sink condition.  Non sink condition – The concentration of receptor compartment is not maintain at lower level as compared to donor compartment.
  • 12. IPQC Sagar Kishor Savale Theories of Drug Dissolution  Diffusion layer model/Film Theory  Danckwert’s model/Penetration or surface renewal Theory  Interfacial barrier model/Double barrier or Limited solvation theory
  • 13. IPQC Sagar Kishor Savale Factor affecting dissolution rate  Physicochemical Properties of Drug  Drug Product Formulation Factors  Processing Factors  Factors Relating Dissolution Apparatus  Factors Relating Dissolution Test Parameters Dissolution test apparatus IP apparatus [1] First is Paddle apparatus (IP) [2] Second is Basket apparatus (IP) USP apparatus 1. Apparatus 1 (rotating basket) 2. Apparatus 2 (paddle assembly) 3. Apparatus 3 (reciprocating cylinder) 4. Apparatus 4 (flow-through cell) 5. Apparatus 5 (paddle over disk) 6. Apparatus 6 (cylinder) 7. Apparatus 7 (reciprocating holder)
  • 14. IPQC Sagar Kishor Savale USP Dissolution apparatus I (Basket method) A single tablet is placed in a small wire mesh basket attached to the bottom of the shaft connected to a variable speed motor. The basket is immersed in a dissolution medium (as specified in monograph) contained in a 1000 ml flask. The flask is cylindrical with a hemispherical bottom. The flask is maintained at 37 ± 0.50 C by a constant temperature bath. The motor is adjusted to turn at the specified speed and sample of the fluid are withdrawn at intervals to determine the amount of drug in solutions.
  • 15. IPQC Sagar Kishor Savale USP Dissolution apparatus II (Paddle method) It is same as apparatus-1, except the basket is replaced by a paddle. The dosage form is allowed to sink to the bottom of the flask before stirring. For dissolution test U.S.P. specifies the dissolution test medium and volume, type of apparatus to be used, rpm of the shaft, time limit of the test and assay procedure for. The test tolerance is expressed as a % of the labeled amount of drug dissolved in the time limit.
  • 16. IPQC Sagar Kishor Savale Dissolution Testing and Interpretation IP Standards Sr.no. Quantity Stage/level Number of tablets tested Acceptance criteria 1 S1 6 Each unit is < D* + 5 percent** 2 S2 6 Average of 12 units (S1 +S2) is equal to or greater than (> )D, and no unit is less than D - 15 percent** 3 S3 12 Average of 24 units (S1+S2+S3) is equal to or greater than (> )D, not more than 2 units are less than d-15 percent** and no unit is less than d-25 percent** *D is the amount of dissolved active ingredient specified in the individual monograph, expressed as a percentage of the labelled content. ** Percentages of the labelled content. Dosage from conducted dissolution study Immediate release tablet (conventional tablet) 1. Dissolution apparatus – Type 1 and Type 2 (USP) 2. Temperature - 37±0.5˚C 3. Time – 30 min 4. Time of interval – 5, 10, 15, 20, 25, 30. 5. Media – PH 1.2 Acidic Buffer, PH 4.5 Acetate buffer, PH 5.8 Phosphate buffer. (depending upon tablet) 6. Rpm – 75 -100 rpm 7. Volume – 900 ml Procedure: The tablet was added into cylindrical vessel containing 1000 ml dissolution media having rpm 75 and tem.37±0.5˚C. Dissolution of tablet was conducted 30 min, in 5 min. of interval, after 5 min 5 mL sample was removed and appropriate quantity of sample take absorbance by using U.V. spectroscopy technique and determine rate of dissolution of tablet.
  • 17. IPQC Sagar Kishor Savale Sustained release tablet 1. Dissolution apparatus – Type 2 (USP) 2. Temperature - 37±0.5˚C 3. Time – 7 hrs 4. Media – PH 1.2 Acidic Buffer, PH 6.8 Phosphate buffer. 5. Rpm – 75 – 100. 6. Volume – 900 ml. Procedure - The tablet was added into cylindrical vessel containing 1000 ml PH 1.2 Acidic media having rpm 75 for next two hours and tem. 37±0.5˚C. Dissolution media was changes tablet was added in to PH 6.8 Phosphate buffer for next five hour for 1 hr. of interval. After 1 hr. 5 mL sample was removed and appropriate quantity of sample take absorbance by using U.V. spectroscopy technique and determine rate of dissolution of tablet. Capsule 1. Dissolution apparatus – Type 2 (USP) 2. Temperature - 37±0.5˚C 3. Time – 5 hrs. 4. Media – PH 1.2 Acidic Buffer, PH 6.8 Phosphate buffer. 5. Rpm – 75 – 100. 6. Volume – 900 ml. Procedure - The Capsule was added into cylindrical vessel containing 1000 ml PH 1.2 Acidic media having rpm 75 for next two hours and tem. 37±0.5˚C. Dissolution media was changes Capsule was added in to PH 6.8 Phosphate buffer for next three hour for 1 hr. of interval. After 1 hr. 5 mL sample was removed and appropriate quantity of sample take absorbance by using U.V. spectroscopy technique and determine rate of dissolution of Capsule.
  • 18. IPQC Sagar Kishor Savale Suppositories 1. Dissolution apparatus – Type 1 (USP) 2. Temperature - 37±0.5˚C 3. Time – 60 min 4. Time of interval – 10, 20, 30, 40, 50, 60. 5. Media – PH 7.4 Phosphate buffer. 6. Rpm – 50 – 75 rpm 7. Volume – 900 ml. Procedure – The Suppository was added into cylindrical vessel containing 1000 ml dissolution media (PH 7.4 Phosphate buffer) having rpm 75 and tem.37±0.5˚C. Dissolution of Suppository was conducted 60 min, in 10 min. of interval, after 10 min 5 ml sample was removed and appropriate quantity of sample take absorbance by using U.V. spectroscopy technique and determine rate of dissolution of Suppositories. 5. Hardness Tablet requires a certain amount of strength or hardness and resistance to friability to withstand mechanical shocks of handling in manufacture, packaging and shipping. Hardness generally measures the tablet crushing strength. Importance  To determine the need for pressure adjustments on the tableting machine.  Hardness can affect the disintegration.  So if the tablet is too hard, it may not disintegrate in the required period of time. And if the tablet is too soft, it will not withstand the handling during subsequent processing such as coating or packaging.  In general, if the tablet hardness is too high, we first check its disintegration before rejecting the batch.  If the disintegration is within limit, we accept the batch.
  • 19. IPQC Sagar Kishor Savale  If Hardness is high + disintegration is within a time accept the batch. Factors Affecting the Hardness [1] Compression of the tablet and compressive force. [2] Amount of binder. (More binder à more hardness) [3] Method of granulation in preparing the tablet (wet method gives more hardness than direct method, Slugging method gives the best hardness). Limits 5 kilograms minimum and 8 kilograms maximum. Make hardness test on 5 tablets and then take the average hardness.
  • 20. IPQC Sagar Kishor Savale 6. Friability Friability of a tablet can determine in laboratory by Roche friabilator. This consist of a plastic chamber that revolves at 25 rpm, dropping the tablets through a Distance of six inches in the friabilator, which is then operate for 100 revolutions. The tablets are reweighed. Compress tablet that lose less than 0.5 to 1.0 % of the Tablet weigh are consider acceptable. Friability apparatus Evaluation of Precompressional Characteristics of tablets or Rheological Characteristics of granules Particle Size & Shape Determination  Size affects the average weight of tablet, Disintegration Time, weight variation, friability, flow ability & drying rate.  The size & shape depends upon processing requirements & during granulation.  The methods for determining size & shape are 1. Sieving 2. Sedimentation rate. 3. Microscopy (SEM) 4. Light Scattering
  • 21. IPQC Sagar Kishor Savale Surface area  It is not commonly used for granules but generally used for drug substances.  If required particle size is measured & from this surface area is measured.  Most method used is gas absorption & air permeability.  In gas absorption, gas is absorbed as monolayer on particles this is in term of calculated & converted to surface area.  In air permeability method the rate of air permeates a bed of powder, is used to calculate surface area of powder sample. Density  Density may influence compressibility, tablet porosity & dissolution.  Dense hard granules may require higher load to produce cohesive compact to reduce free granules seen on the surface of tablets.  ↑ Compressibility ↑ DT, Dissolution, if DT is slower dissolution is indirectly hampered.  Dense granules have less friability but cause a problem in releasing the drug.  Three Methods to determine density Bulk Density Bulk density is given by equation, ρb = M / Vb Where, ρb- bulk density of granules, M is mass of granules in gm, Vb – volume of granules in measuring cylinder in ml. More compressible bed of particulate - less flowable powder or granules. If less dense/compressible - more flowable powder or granules. True/tapped density Tapped/true density is given by equation, ρt = M / Vb Where,
  • 22. IPQC Sagar Kishor Savale ρt- bulk density of granules, M is mass of granules in gm, Vt – volume of granules in measuring cylinder after tapping in ml. Granular density It is determined by Pycnometer method.  Two methods are used to determined granular density.  In one intrusion fluid used-Mercury, and other Any solvent of low surface tension e.g. Benzene  The accuracy of these method depends upon ability of intrusion fluid to penetrate the pores of granules.  Liquids should not masks granules solubilies in it, & having property to penetrate the pores.  Density is then determine from volume of intrusion fluid displaced in pycnometer by giving mass of granulation. It is calculated by using equation, Granular Density (D) = M / Vp -Vi Where, Vp-Total volume of Pycnometer, Vi- Volume of intrusion fluid (ml) containing Mass (gm) (M) of granules required to fill pycnometer. Angle of repose – It is measured by two methods  Static angle of repose  Dynamic angle of repose Equation is, tan θ = h/r. Where, θ - angle of repose, h – height of pile, r – radius of pile.
  • 23. IPQC Sagar Kishor Savale Acceptance limits of angle of repose Sr. no. Angle of repose (o) Type of flow 1 < 25 Excellent 2 25-30 Good 3 30-40 passable 4 > 40 Poor Hausner's Ratio  Hausner’s ratio was related to interparticulate friction and as such could be used to predict powder flow characteristics.  It showed that powder with low particular friction such as coarse sphere had ratio of approximately 1.2, whereas more as cohesiveness- less free flowing powders such as flaks have Hausner’s ratio greater than 1.6. Formula Hausner’s ratio = Tapped density / Bulk density
  • 24. IPQC Sagar Kishor Savale Moisture content  The amount of moisture present in the granule is called moisture content.  Generally the granules contain 2 % moisture. It is required for the binding of the powder or granules during compression in die cavity.  Percentage of moisture is calculated by using “moisture Balance” or “IR Balance”.  IR Balance consist of simple balance which is placed I to the casing in which the IR bulb is attached which produce heat inside the chamber.  The small amount of sample taken from oven to measure moisture content & place in the moisture balance.  Initial reading should be note down after that we are initiated the IR Bulb as IR bulb is initiated the moisture is removed from the granules via heating after that note down the reading. % of moisture is calculated by, % moisture content = Initial wt. - Final wt./ initial weight X 100 Compressibility Index  It is directly related to the relative flow rate cohesiveness & particle size.  It is simple fast & popular method of presiding powder flow characters. It can be obtained from bulk density measurements is the % Compressibility index (C). % Compressibility index = Tapped density - Bulk density / Tapped density X 100. OR I = (1 – V/ Vo) x 100 Where, I – % Compressibility index, V – Volume occupied by powder/ granules after tapping, Vo - volume of powder/granules before tapping
  • 25. IPQC Sagar Kishor Savale Acceptance limit Compressibility index Sr. no. % Compressibility index Type of flow 1 5-15 Excellent 2 12-16 Very good 3 18-21 Good 4 23-25 Passable 5 33-38 Poor 6 > 40 Very poor
  • 26. IPQC Sagar Kishor Savale Process control by means of in-process controls
  • 27. IPQC Sagar Kishor Savale Example of an IPQC structure
  • 28. IPQC Sagar Kishor Savale Example of Approval for Tablet Production Contact Savalesagar484@gmail.com +91 9960885333